Clinical trials recruiting for Colon Cancer Stage III
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Adjuvant chemotherapy | 1 |
| Dostarlimab | 1 |
| mFOLFIRINOX | 1 |
| mFOLFOX-6 | 1 |
| neoadjuvant chemotherapyI | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
Top cities
Self-screener
Recruiting trials
- Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
- Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
- Phase II Study of Neoadjuvant Dostarlimab in Patients With Untreated T3-4N0-2 or Stage III pMMR/MSS Resectable Colon Cancer
- Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Related conditions
Trials recruiting for Colon Cancer Stage III often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Colon Cancer Stage III trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.